ETF Managers Group, LLC Revance Therapeutics, Inc. Transaction History

ETF Managers Group, LLC

  • $2.78 Billion
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$11.52 - $20.4 $218,396 - $386,743
18,958 New
18,958 $270,000
Q2 2021

Aug 16, 2021
SELL
$26.8 - $31.84 $909,324 - $1.08 Million
-33,930 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$24.03 - $29.97 $815,337 - $1.02 Million
33,930 New
33,930 $945,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email